Arrhythmia Research Technology (HRT) Reports Q2 EPS of $0.02
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
Weighted Average Number of Shares Outstanding, Diluted: 2.82M
Today's EPS Names:
NSLR, OCTV, ACB, More
Financial Fact:
Weighted Average Number of Shares Outstanding, Diluted: 2.82M
Today's EPS Names:
NSLR, OCTV, ACB, More
Join SI Premium – FREE
Arrhythmia Research Technology (NYSE: HRT) reported Q2 EPS of $0.02, versus $0.04 reported last year. Revenue for the quarter came in at $5.13 million, versus $5.66 million reported last year.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
- Erasca, Inc. (ERAS) Misses Q2 EPS by 3c
- Transact Technologies (TACT) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
